Béa Fertility is developing the world’s first clinical-grade at-home fertility treatment. Co-founded by femtech expert Tess Cosad, medical doctor Dr Louise Rix and product engineer George Thomas, the company is creating a new, accessible and affordable first step on the fertility journey for people who are struggling to conceive. 

When it launches, the Béa device will be a new, transformational step in the fertility treatment pathway. The first Béa device will enable people struggling to conceive to carry out a simple fertility treatment called Intracervical Insemination (ICI) safely at home, before costly clinical treatment options are explored. ICI has been shown to have efficacy of 50% over 6 cycles of treatment, and was recently included in the NICE clinical guidelines as a recommended approach to fertility treatment. Béa Fertility’s ICI Treatment Kit will launch in summer 2023.

Béa Fertility raised $1m in pre-seed funding last year to expand their team and bring their pioneering fertility solution to market. The round was led by Q Ventures and Calm/Storm VC.

As a key Advisor, Darren will help steer Béa’s marketing and growth strategies, with the aim of making the Béa device a category leader. He will support the creation of a winning commercial infrastructure to support both UK and international growth, working with the CEO on brand strategy, positioning, growth and fundraising.

Darren brings over twenty-five years’ global marketing and commercial experience to Béa Fertility, from the likes of Apple, L’Oreal, P&G, Paramount Pictures, Elvie and Babylon Health. He was most recently Chief Marketing Officer at Zumper: the largest privately-owned rental platform in North America, with more than 178 million site visits per year.

Darren Goode comments:

“I’m really excited to be joining Tess and the wider Béa team at this critical stage in their journey. My first child was born through IVF, so I’m acutely aware of the complex challenges surrounding fertility. Currently, there’s really nothing available between trying (and struggling) to conceive and going to a fertility clinic. This is what drew me to Béa. This is the first time I’ve seen fertility innovation that isn’t just offering advice or a new route into clinics, but is getting to the very heart of the problem and offering a totally new treatment solution. 

“My role will be equal parts operational, practical, philosophical and pastoral. Tess is an inspiring founder and I can't wait to see where we can take this.”

Tess Cosad, CEO and co-founder at Béa Fertility, comments:

I’ve been working with Darren since the inception of Béa, and at every step of the journey his advice has been invaluable. I couldn’t think of a better leader and advocate to have in our corner, and look forward to seeing where we can take the company with Darren on board.”